Receptor/Gene-Mediated Pharmacodynamic Effects of Methylprednisolone on Phosphoenolpyruvate Carboxykinase Regulation in Rat Liver

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 328-339

  Jin, Jin Y ^a   DuBois, Debra C ^a   Almon, Richard R ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCOSE; MESSENGER RNA; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEGRADATION; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; LIVER; MALE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; SINGLE DRUG DOSE;

ANIMALS; CYCLIC AMP; GLUCOCORTICOIDS; LIVER; METHYLPREDNISOLONE; ORGAN SIZE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 1642346630     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.061515     Document Type: Article

References (40)

1. Barnett CA and Wicks WD (1971) Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. I. Effects of glucocorticoids, N6,O2′-dibutyryl cyclic adenosine 3′,5′ -monophosphate and insulin in Reuber H35 cells. J Biol Chem 246:7201-7206.
2. Baus E, Van Laethem F, Andris F, Rolin S, Urbain J, and Leo O (2001) Dexamethasone increases intracellular cyclic AMP concentration in murine T lymphocyte cell lines. Steroids 66:39-47.
3. Baxter JD (1976) Glucocorticoid hormone action. Pharmacol Ther 2:605-669.
4. Brooker G (1982) Radioimmunoassay techniques for cyclic nucleotides, in Cyclic Nucleotides. Part I: Biochemistry (Nathanson JA and Kebabian JW eds) pp 325-332, Springer, New York.
5. Burlini N, Morandi S, Pellegrini R, Tortora P, and Guerritore A (1989) Studies on the degradative mechanism of phosphoenolpyruvate carboxykinase from yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1014:153-161.
6. Butcher RW, Robison GA, Hardman JG, and Sutherland EW (1968) The role of cyclic AMP in hormone actions. Adv Enzyme Regul 6:357-389.
7. Christoffersen T, Refsnes M, Bronstad GO, Ostby E, Huse J, Haffner F, Sand TE, Hunt NH, and Sonne O (1984) Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone. Eur J Biochem 138:217-226.
8. D'Argenio DZ and Schumitzky A (1997) ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. BioMedical Simulations Resource, Los Angeles, CA.
9. DuBois DC, Almon RR, and Jusko WJ (1993) Molar quantification of specific messenger ribonucleic acid expression in northern hybridization using cRNA standards. Anal Biochem 210:140-144.
10. Granner DK and Andreone TL (1985) Insulin modulation of gene expression. Diabetes Metab Rev 1:139-170.
11. Granner DK, Sasaki K, and Chu D (1986) Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. Ann NY Acad Sci 478:175-190.
12. Gunn JM, Ballard FJ, and Hanson RW (1976) Influence of hormones and medium composition on the degradation of phosphoenolpyruvate carboxykinase (GTP) and total protein in Reuber H35 cells. J Biol Chem 251:3586-3593.
13. Gunn JM, Hanson RW, Meyuhas O, Reshef L, and Ballard FJ (1975a) Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in the rat. Biochem J 150:195-203.
14. Gunn JM, Tilghman SM, Hanson RW, Reshef L, and Ballard FJ (1975b) Effects of cyclic adenosine monophosphate, dexamethasone and insulin on phosphoenolpyruvate carboxykinase synthesis in Reuber H-35 hepatoma cells. Biochemistry 14:2350-2357.
15. Hanson RW and Reshef L (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611.
16. Haughey DB and Jusko WJ (1988) Analysis of methylprednisolone, methylprednisone and corticosterone for assessment of methylprednisolone disposition in the rat. J Chromatogr 430:241-248.
17. Hege Thoresen G, Gjone IH, Gladhaug IP, Refsnes M, Ostby E, and Christoffersen T (1989) Studies of glucocorticoid enhancement of the capacity of hepatocytes to accumulate cyclic AMP. Pharmacol Toxicol 65:175-180.
18. Hogger P and Rohdewald P (1998) Glucocorticoid receptors and fluticasone propionate. Rev Contemp Pharmacother 9:501-522.
19. Hoppner W, Sussmuth W, O'Brien C, and Seitz HJ (1986) Cooperative effect of thyroid and glucocorticoid hormones on the induction of hepatic phosphoenolpyruvate carboxykinase in vivo and in cultured hepatocytes. Eur J Biochem 159:399-405.
20. Jusko WJ (1994) Receptor-mediated pharmacodynamics of corticosteroids. Prog Clin Biol Res 387:261-270.
21. Krone W, Marquardt W, Seitz HJ, and Tarnowski W (1975) Effect of cordycepin and cycloheximide on the induction of phosphoenolpyruvate carboxykinase by dexamethasone or N6,O2′-dibutyrylcyclic AMP in the isolated perfused rat liver. FEBS Lett 57:64-67.
22. McGraw CA, Vawter GF, and Hug G (1986) Phosphoenolpyruvate carboxykinase activity in human liver. Forensic Sci Int 30:143-154.
23. Oakley RH and Cidlowski JA (1993) Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 3:63-88.
24. O'Brien RM and Granner DK (1990) PEPCK gene as model of inhibitory effects of insulin on gene transcription. Diabetes Care 13:327-339.
25. O'Brien RM, Printz RL, Halmi N, Tiesinga JJ, and Granner DK (1995) Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochim Biophys Acta 1264:284-288.
26. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, and Jusko WJ (2002a) Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn 29:1-24.
27. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, and Jusko WJ (2002b) Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J Pharmacol Exp Ther 300:245-256.
28. Robison GA, Butcher RW, and Sutherland EW (1971a) Appendix on the assay of cyclic AMP, in Cyclic AMP (Robison GA, Butcher RW, and Sutherland EW eds) pp 456-478, Academic Press, New York.
29. Robison GA, Butcher RW, and Sutherland EW (1971b) Cyclic AMP and hormone action, in Cyclic AMP (Robison GA, Butcher RW, and Sutherland EW eds) pp 17-47, Academic Press, New York.
30. Schimmer BP and Parker KL (1996) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones., in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, and Gilman AG eds) pp 1459-1485, McGraw-Hill Companies, New York.
31. Sharma R and Patnaik SK (1984) Regulation of citrate synthase and phosphoenolpyruvate carboxykinase by hydrocortisone in the liver of aging rats. Arch Gerontol Geriatr 3:167-174.
32. Sun YN, DuBois DC, Almon RR, and Jusko WJ (1998a) Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm 26:289-317.
33. Sun YN, DuBois DC, Almon RR, Pyszczynski NA, and Jusko WJ (1998b) Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm 26:619-648.
34. Sun YN and Jusko WJ (1998) Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J Pharm Sci 87:732-737.
35. Sun YN, McKay LI, DuBois DC, Jusko WJ, and Almon RR (1999) Pharmacokinetic/ pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/gene-mediated mechanism. J Pharmacol Exp Ther 288:720-728.
36. Wicks WD (1971) Differential effects of glucocorticoids and adenosine 3′, 5′-monophosphate on hepatic enzyme synthesis. J Biol Chem 246:217-223.
37. Wicks WD (1974) Regulation of protein synthesis by cyclic AMP. Adv Cyclic Nucleotide Res 4:335-438.
38. Wicks WD, Lewis W, and McKibbin JB (1972) Induction of phosphoenolpyruvate carboxykinase by N6,O2′-dibutyryl cyclic AMP in rat liver. Biochim Biophys Acta 264:177-185.
39. Wimmer M (1988) A bioluminescent assay for the determination of phosphoenolpyruvate carboxykinase activity in nanogram-sized tissue samples. Anal Biochem 170:376-381.
40. Yingling JD, Fuller LZ, and Jackson BA (1994) Modulation of cyclic AMP metabolism by glucocorticoids in PC18 cells. J Neurochem 63:1271-1276.